{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:34:29Z","timestamp":1789385669347,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T00:00:00Z","timestamp":1367625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2296-14-55","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T16:14:29Z","timestamp":1367684069000},"source":"Crossref","is-referenced-by-count":64,"title":["Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews"],"prefix":"10.1186","volume":"14","author":[{"given":"Alain","family":"Mercier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Auger-Aubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Lebeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Schuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Boulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Loup","family":"Hermil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Van Royen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Peremans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,4]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0013-7006(05)82386-3","volume":"31","author":"I Gasquet","year":"2005","unstructured":"Gasquet I, N\u00e8gre-Pag\u00e8s L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, L\u00e9pine J-P: [Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD\/MHEDEA 2000 epidemiological study]. Encephale. 2005, 31: 195-206. 10.1016\/S0013-7006(05)82386-3.","journal-title":"Encephale"},{"key":"846_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/archgenpsychiatry.2009.81","volume":"66","author":"M Olfson","year":"2009","unstructured":"Olfson M, Marcus SC: National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009, 66: 848-10.1001\/archgenpsychiatry.2009.81.","journal-title":"Arch Gen Psychiatry"},{"key":"846_CR3","unstructured":"Ventes de m\u00e9dicaments aux officines et aux h\u00f4pitaux en France: chiffres cl\u00e9s 2010. Rapport d\u2019expertise. (Sales of medicines to pharmacies and hospitals in France: key figures 2010. Expertise). 2010, http:\/\/ansm.sante.fr\/content\/download\/35989\/470166\/version\/4\/file\/chiffres-cle-venteMedicaments2010.pdf , . Rapport d\u2019expertise. (Sales of medicines to pharmacies and hospitals in France: key figures 2010. Expertise),"},{"key":"846_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-0047.2004.00325.x","volume":"109","author":"J Alonso","year":"2004","unstructured":"Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, De Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, L\u00e9pine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Mart\u00ednez-Alonso M, Matschinger H: Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004, 109: 55-64.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"846_CR5","first-page":"1139","volume":"190","author":"J Lepine","year":"2006","unstructured":"Lepine J, Gasquet IF: [Psychotropic drug use in France: changes over time and comparison with other European countries]. Bull Acad Natl Med. 2006, 190: 1139-1145.","journal-title":"Bull Acad Natl Med"},{"key":"846_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00228-004-0810-8","volume":"60","author":"A Ciuna","year":"2004","unstructured":"Ciuna A, Andretta M, Corbari L, Levi D, Mirandola M, Sorio A, Barbui C: Are we going to increase the use of antidepressants up to that of benzodiazepines?. Eur J Clin Pharmacol. 2004, 60: 629-634. 10.1007\/s00228-004-0810-8.","journal-title":"Eur J Clin Pharmacol"},{"key":"846_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/ageing\/afl023","volume":"35","author":"DR Petty","year":"2006","unstructured":"Petty DR, House A, Knapp P, Raynor T, Zermansky A: Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing. 2006, 35: 523-526. 10.1093\/ageing\/afl023.","journal-title":"Age Ageing"},{"key":"846_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.sapharm.2007.06.019","volume":"4","author":"Y Chen","year":"2008","unstructured":"Chen Y, Kelton CML, Jing Y, Guo JJ, Li X, Patel NC: Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Res Social Adm Pharm. 2008, 4: 244-257. 10.1016\/j.sapharm.2007.06.019.","journal-title":"Res Social Adm Pharm"},{"key":"846_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.4088\/JCP.v69n0704","volume":"69","author":"R Mojtabai","year":"2008","unstructured":"Mojtabai R, Olfson M: National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. J Clin Psychiatry. 2008, 69: 1064-1074. 10.4088\/JCP.v69n0704.","journal-title":"J Clin Psychiatry"},{"key":"846_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta15280","volume":"15","author":"CAC Coupland","year":"2011","unstructured":"Coupland CAC, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J: A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess. 2011, 15: 1-202. iii\u2013iv","journal-title":"Health Technol Assess"},{"key":"846_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.encep.2007.07.011","volume":"34","author":"A Grolleau","year":"2008","unstructured":"Grolleau A, Cougnard A, B\u00e9gaud B, Verdoux H: [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey]. Enc\u00e9phale. 2008, 34: 352-359.","journal-title":"Enc\u00e9phale"},{"key":"846_CR12","doi-asserted-by":"publisher","first-page":"e14784","DOI":"10.1371\/journal.pone.0014784","volume":"6","author":"E Piek","year":"2011","unstructured":"Piek E, van der Meer K, Hoogendijk WJG, Penninx BWJH, Nolen WA: Most antidepressant use in primary care is justified; results of the netherlands study of depression and anxiety. PLoS One. 2011, 6: e14784-10.1371\/journal.pone.0014784.","journal-title":"PLoS One"},{"key":"846_CR13","doi-asserted-by":"crossref","unstructured":"Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, MacGillivray S: Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev. 2009, Art. No.: CD007954-10.1002\/14651858. CD007954, Issue 3","DOI":"10.1002\/14651858.CD007954"},{"key":"846_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4088\/JCP.10m06760","volume":"73","author":"JA Stewart","year":"2012","unstructured":"Stewart JA, Deliyannides DA, Hellerstein DJ, McGrath PJ, Stewart JW: Can people with nonsevere major depression benefit from antidepressant medication?. J Clin Psychiatry. 2012, 73: 518-525. 10.4088\/JCP.10m06760.","journal-title":"J Clin Psychiatry"},{"key":"846_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.eurpsy.2009.07.012","volume":"25","author":"MC Serna","year":"2010","unstructured":"Serna MC, Cruz I, Real J, Gasc\u00f3 E, Galv\u00e1n L: Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database. Eur Psychiatry. 2010, 25: 206-213.","journal-title":"Eur Psychiatry"},{"key":"846_CR16","doi-asserted-by":"publisher","first-page":"b3999","DOI":"10.1136\/bmj.b3999","volume":"339","author":"M Moore","year":"2009","unstructured":"Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T: Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009, 339: b3999-10.1136\/bmj.b3999.","journal-title":"BMJ"},{"key":"846_CR17","first-page":"203","volume":"26","author":"EA Kerr","year":"2000","unstructured":"Kerr EA, McGlynn EA, Van Vorst KA, Wickstrom SL: Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement. Jt Comm J Qual Improv. 2000, 26: 203-216.","journal-title":"Jt Comm J Qual Improv"},{"key":"846_CR18","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1377\/hlthaff.2010.1024","volume":"30","author":"R Mojtabai","year":"2011","unstructured":"Mojtabai R, Olfson M: Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff. 2011, 30: 1434-1442. 10.1377\/hlthaff.2010.1024.","journal-title":"Health Aff"},{"key":"846_CR19","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4088\/JCP.v67n0615","volume":"67","author":"H Chen","year":"2006","unstructured":"Chen H, Reeves JH, Fincham JE, Kennedy WK, Dorfman JH, Martin BC: Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001. J Clin Psychiatry. 2006, 67: 972-982. 10.4088\/JCP.v67n0615.","journal-title":"J Clin Psychiatry"},{"key":"846_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10488-006-0088-5","volume":"34","author":"MJ Larson","year":"2007","unstructured":"Larson MJ, Miller K, Fleming KJ: Treatment with antidepressant medications in private health plans. Adm Policy Ment Health. 2007, 34: 116-126. 10.1007\/s10488-006-0088-5.","journal-title":"Adm Policy Ment Health"},{"key":"846_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1471-2296-12-99","volume":"12","author":"A Mercier","year":"2011","unstructured":"Mercier A, Auger-Aubin I, Lebeau J-P, Van Royen P, Peremans L: Understanding the prescription of antidepressants: a qualitative study among French GPs. BMC Fam Pract. 2011, 12: 99-10.1186\/1471-2296-12-99.","journal-title":"BMC Fam Pract"},{"key":"846_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1468-1331.2004.00867.x","volume":"11","author":"M Brainin","year":"2004","unstructured":"Brainin M, Barnes M, Baron J-C, Gilhus NE, Hughes R, Selmaj K, Waldemar G: Guidance for the preparation of neurological management guidelines by EFNS scientific task forces\u2013revised recommendations 2004. Eur J Neurol. 2004, 11: 577-581. 10.1111\/j.1468-1331.2004.00867.x.","journal-title":"Eur J Neurol"},{"key":"846_CR23","volume-title":"Quelle place pour la pr\u00e9gabaline dans les douleurs neuropathiques (What place for pregabalin in neuropathic pain ?)","author":"Haute autorit\u00e9 de sant\u00e9 (HAS)","year":"2007","unstructured":"Haute autorit\u00e9 de sant\u00e9 (HAS): Quelle place pour la pr\u00e9gabaline dans les douleurs neuropathiques (What place for pregabalin in neuropathic pain ?). 2007, Paris: HAS"},{"key":"846_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","volume":"17","author":"N Attal","year":"2010","unstructured":"Attal N, Cruccu G, Baron R, Haanp\u00e4\u00e4 M, Hansson P, Jensen TS, Nurmikko T: EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010, 17: 1113-e88. 10.1111\/j.1468-1331.2010.02999.x.","journal-title":"Eur J Neurol"},{"key":"846_CR25","volume-title":"The pharmacological management of neuropathic pain in adults in non-specialist settings","author":"National Institute for Health and Clinical Excellence","year":"2010","unstructured":"National Institute for Health and Clinical Excellence: The pharmacological management of neuropathic pain in adults in non-specialist settings. 2010, [CG96] London: National Institute for Health and Clinical Excellence"},{"key":"846_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0091270010394852","volume":"52","author":"P Dharmshaktu","year":"2012","unstructured":"Dharmshaktu P, Tayal V, Kalra BS: Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012, 52: 6-17. 10.1177\/0091270010394852.","journal-title":"J Clin Pharmacol"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1136\/jnnp.2008.144964","volume":"81","author":"T Saarto","year":"2010","unstructured":"Saarto T, Wiffen PJ: Antidepressants for neuropathic pain: a Cochrane review. J. Neurol. Neurosurg. Psychiatr. 2010, 81: 1372-1373. 10.1136\/jnnp.2008.144964.","journal-title":"J. Neurol. Neurosurg. Psychiatr"},{"key":"846_CR28","doi-asserted-by":"crossref","unstructured":"Lunn MPT, Hughes RAC, Wiffen PJ: Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev. 2009, Art. No. CD007115-10.1002\/14651858. CD007115.pub2, Issue 4","DOI":"10.1002\/14651858.CD007115.pub2"},{"key":"846_CR29","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1212\/WNL.0b013e3182166ebe","volume":"76","author":"V Bril","year":"2011","unstructured":"Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, Feldman E, Iverson DJ, Perkins B, Russell JW, Zochodne D: Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011, 76: 1758-1765. 10.1212\/WNL.0b013e3182166ebe.","journal-title":"Neurology"},{"key":"846_CR30","doi-asserted-by":"crossref","unstructured":"Alviar MJM, Hale T, Dungca M: Pharmacologic interventions for treating phantom limb pain. Cochrane Database Syst Rev. 2011, Art. No. CD006380-10.1002\/14651858. CD006380.pub2, Issue 12","DOI":"10.1002\/14651858.CD006380.pub2"},{"key":"846_CR31","volume-title":"Diagnosis and management of headache in adults. A national clinical guideline","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2008","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN): Diagnosis and management of headache in adults. A national clinical guideline. 2008, Edinburgh (Scotland): SIGN"},{"key":"846_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","volume":"16","author":"S Evers","year":"2009","unstructured":"Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, S\u00e1ndor PS: EFNS guideline on the drug treatment of migraine\u2013revised report of an EFNS task force. Eur J Neurol. 2009, 16: 968-981. 10.1111\/j.1468-1331.2009.02748.x.","journal-title":"Eur J Neurol"},{"key":"846_CR33","doi-asserted-by":"crossref","unstructured":"Moja L, Cusi C, Sterzi R, Canepari C: Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005, Art. No. CD002919-10.1002\/14651858. CD002919.pub2, Issue 3","DOI":"10.1002\/14651858.CD002919.pub2"},{"key":"846_CR34","volume-title":"Recommandations pour la pratique clinique CCQ (C\u00e9phal\u00e9es chroniques quotidiennes): Diagnostic, R\u00f4le de l\u2019abus m\u00e9dicamenteux, Prise en charge. (Guidelines for diagnostic, management of Chronic daily headache. Role of Substance-related disorders)","author":"Agence national d\u2019accr\u00e9ditation et d\u2019\u00e9valuation en sant\u00e9 (ANAES)","year":"2004","unstructured":"Agence national d\u2019accr\u00e9ditation et d\u2019\u00e9valuation en sant\u00e9 (ANAES): Recommandations pour la pratique clinique CCQ (C\u00e9phal\u00e9es chroniques quotidiennes): Diagnostic, R\u00f4le de l\u2019abus m\u00e9dicamenteux, Prise en charge. (Guidelines for diagnostic, management of Chronic daily headache. Role of Substance-related disorders). 2004, Paris: ANAES"},{"key":"846_CR35","volume-title":"Prise en charge diagnostique et th\u00e9rapeutique des lombalgies et lombosciatiques communes de moins de 3 mois d\u2019\u00e9volution. . (Diagnosis and therapeutic management of acute low back pain, and sciatica)","author":"Agence national d\u2019accr\u00e9ditation et d\u2019\u00e9valuation en sant\u00e9 (ANAES)","year":"2000","unstructured":"Agence national d\u2019accr\u00e9ditation et d\u2019\u00e9valuation en sant\u00e9 (ANAES): Prise en charge diagnostique et th\u00e9rapeutique des lombalgies et lombosciatiques communes de moins de 3 mois d\u2019\u00e9volution. . (Diagnosis and therapeutic management of acute low back pain, and sciatica). 2000, Paris: ANAES"},{"key":"846_CR36","volume-title":"Low back pain Early management of persistent non-specific low back pain","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2009","unstructured":"National Institute for Health and Clinical Excellence (NICE): Clinical guidelines, CG88. Low back pain Early management of persistent non-specific low back pain. 2009"},{"key":"846_CR37","doi-asserted-by":"crossref","unstructured":"Urquhart DM, Hoving JL, Assendelft WJJ, Roland M, van Tulder MW: Antidepressants for non-specific low back pain. Cochrane Database Syst Rev. 2008, Art. No. CD001703-10.1002\/14651858. CD001703.pub3, Issue 1","DOI":"10.1002\/14651858.CD001703.pub3"},{"key":"846_CR38","volume-title":"Assessment and management of chronic pain","author":"Institute for Clinical Systems Improvement (ICSI)","year":"2009","unstructured":"Institute for Clinical Systems Improvement (ICSI): Assessment and management of chronic pain. 2009, Bloomington (MN): Institute for Clinical Systems Improvement (ICSI), Nov. 91 p. [187 references]"},{"key":"846_CR39","doi-asserted-by":"crossref","unstructured":"Zakrzewska JM, Forssell H, Glenny A-M: Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev. 2005, Art. No. CD002779-10.1002\/14651858. CD002779.pub2, Issue 1","DOI":"10.1002\/14651858.CD002779.pub2"},{"key":"846_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.7326\/0003-4819-148-5-200803040-00008","volume":"148","author":"A Qaseem","year":"2008","unstructured":"Qaseem A, Snow V, Cross JT, Forciea MA, Hopkins R, Shekelle P, Adelman A, Mehr D, Schellhase K, Campos-Outcalt D, Santaguida P, Owens DK: Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2008, 148: 370-378. 10.7326\/0003-4819-148-5-200803040-00008.","journal-title":"Ann Intern Med"},{"key":"846_CR41","doi-asserted-by":"crossref","unstructured":"Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P: Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev. 2011, Art. No. CD008191-10.1002\/14651858.CD008191.pub2. Issue 2,","DOI":"10.1002\/14651858.CD008191.pub2"},{"key":"846_CR42","volume-title":"Maladie d\u2019Alzheimer et maladies apparent\u00e9es: prise en charge des troubles du comportement perturbateurs","author":"Haute autorit\u00e9 de sant\u00e9 (HAS)","year":"2009","unstructured":"Haute autorit\u00e9 de sant\u00e9 (HAS): (Alzheimer\u2019s disease and Alzheimer\u2019s related diseases. Management of disruptive behaviour). Maladie d\u2019Alzheimer et maladies apparent\u00e9es: prise en charge des troubles du comportement perturbateurs. 2009, Paris: HAS"},{"key":"846_CR43","doi-asserted-by":"crossref","unstructured":"Ghazi-Noori S, Chung TH, Deane K, Rickards HE, Clarke CE: Therapies for depression in Parkinson's disease. Cochrane Database Syst Rev. 2003, Art. No.: CD003465-10.1002\/14651858.CD003465. Issue 3","DOI":"10.1002\/14651858.CD003465"},{"key":"846_CR44","doi-asserted-by":"crossref","unstructured":"Hackett ML, Yang M, Anderson CS, Horrocks JA, House A: Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev. 2010, Art. No. CD003690-10.1002\/14651858.CD003690.pub3. Issue 2","DOI":"10.1002\/14651858.CD003690.pub3"},{"key":"846_CR45","volume-title":"Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning","author":"Scottish Intercollegiate Guidelines Network","year":"2010","unstructured":"Scottish Intercollegiate Guidelines Network: A national clinical guideline. Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning. 2010, SIGN ISBN 978 1 905813 63 6, June 2010 [Available at http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/118\/ ]"},{"key":"846_CR46","doi-asserted-by":"crossref","unstructured":"Hackett ML, Anderson CS, House A, Halteh C: Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008, Art. No. CD003689-10.1002\/14651858. CD003689.pub3, Issue 3","DOI":"10.1002\/14651858.CD003689.pub3"},{"key":"846_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1474-4422(10)70314-8","volume":"10","author":"F Chollet","year":"2011","unstructured":"Chollet F, Tardy J, Albucher J-F, Thalamas C, Berard E, Lamy C, Bejot Y, Deltour S, Jaillard A, Niclot P: Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011, 10: 123-130. 10.1016\/S1474-4422(10)70314-8.","journal-title":"Lancet Neurol"},{"key":"846_CR48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","volume":"4","author":"S Schutte-Rodin","year":"2008","unstructured":"Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M: Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008, 4: 487-504.","journal-title":"J Clin Sleep Med"},{"key":"846_CR49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5664\/jcsm.27716","volume":"6","author":"R Hoque","year":"2010","unstructured":"Hoque R, Chesson AL: Pharmacologically induced\/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder\/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med. 2010, 6: 79-83.","journal-title":"J Clin Sleep Med"},{"key":"846_CR50","doi-asserted-by":"crossref","unstructured":"Young CA, Ellis C, Johnson J, Sathasivam S, Pih N: Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis. Cochrane Database Syst Rev. 2011, Art. No. CD006981-10.1002\/14651858. CD006981.pub2, Issue 5","DOI":"10.1002\/14651858.CD006981.pub2"},{"key":"846_CR51","doi-asserted-by":"crossref","unstructured":"Baldo P, Doree C, Molin P, McFerran D, Cecco S: Antidepressants for patients with tinnitus. Cochrane Database Syst Rev. 2012, Art. No. CD003853-10.1002\/14651858.CD003853.pub3. Issue 9,","DOI":"10.1002\/14651858.CD003853.pub3"},{"key":"846_CR52","first-page":"4","volume-title":"2010 addendum to 2009 urinary incontinence guidelines","author":"M Lucas","year":"2010","unstructured":"Lucas M, Bosch R, Cruz F, de Ridder D, Neisius A, Pickard R, Schr\u00f6der A, Tubaro A, Turner W: 2010 addendum to 2009 urinary incontinence guidelines. 2010, Arnhem, The Netherlands: European Association of Urology (EAU), 4-"},{"key":"846_CR53","doi-asserted-by":"crossref","unstructured":"Mariappan P, Alhasso AA, Grant A, N\u2019Dow JMO: Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults. Cochrane Database Syst Rev. 2005, Art. No. CD004742-10.1002\/14651858. CD004742.pub2, Issue 3","DOI":"10.1002\/14651858.CD004742.pub2"},{"key":"846_CR54","first-page":"CD003190","volume-title":"Cochrane Database Syst Rev","author":"C Roxburgh","year":"2007","unstructured":"Roxburgh C, Cook J, Dublin N: Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database Syst Rev. 2007, CD003190-"},{"key":"846_CR55","volume-title":"Prise en charge de l\u2019incontinence urinaire de la femme en m\u00e9decine g\u00e9n\u00e9rale","author":"Agence Nationale d\u2019Accr\u00e9ditation et d\u2019\u00c9valuation en Sant\u00e9 (ANAES)","year":"2003","unstructured":"Agence Nationale d\u2019Accr\u00e9ditation et d\u2019\u00c9valuation en Sant\u00e9 (ANAES): Recommandations. (Guidelines for management of female urinary incontinence in general practice). Prise en charge de l\u2019incontinence urinaire de la femme en m\u00e9decine g\u00e9n\u00e9rale. 2003, Paris: ANAES"},{"key":"846_CR56","volume-title":"Cochrane Database of Systematic Reviews","author":"J Brown","year":"2009","unstructured":"Brown J, O\u2019Brien PMS, Marjoribanks J, Wyatt K: Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews. Edited by: The Cochrane Collaboration, Brown J. 2009, Chichester, UK: John Wiley & Sons, Ltd"},{"key":"846_CR57","doi-asserted-by":"crossref","unstructured":"Rada G, Capurro D, Pantoja T, Corbal\u00e1n J, Moreno G, Letelier LM, Vera C: Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev. 2010, Art. No. CD004923-10.1002\/14651858.CD004923.pub2. Issue 9,","DOI":"10.1002\/14651858.CD004923.pub2"},{"key":"846_CR58","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","volume":"57","author":"K Hatzimouratidis","year":"2010","unstructured":"Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E: Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010, 57: 804-814. 10.1016\/j.eururo.2010.02.020.","journal-title":"Eur Urol"},{"key":"846_CR59","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1345\/aph.1E069","volume":"39","author":"AJ Moreland","year":"2005","unstructured":"Moreland AJ, Makela EH: Selective serotonin-reuptake inhibitors in the treatment of premature ejaculation. Ann Pharmacother. 2005, 39: 1296-1301. 10.1345\/aph.1E069.","journal-title":"Ann Pharmacother"},{"key":"846_CR60","doi-asserted-by":"crossref","unstructured":"Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007, Art. No. CD000031-10.1002\/14651858.CD000031.pub3. Issue 1","DOI":"10.1002\/14651858.CD000031.pub3"},{"key":"846_CR61","volume-title":"Alcohol-use disorders. Diagnosis, assessment and management of harmful drinking and alcohol dependence","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2011","unstructured":"National Institute for Health and Clinical Excellence (NICE): Alcohol-use disorders. Diagnosis, assessment and management of harmful drinking and alcohol dependence. 2011, CG 115 London: National Institute for Health and Clinical Excellence"},{"key":"846_CR62","doi-asserted-by":"crossref","unstructured":"Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M: Antidepressants for depression in physically ill people. Cochrane Database Syst Rev. 2010, Art. No. CD007503-10.1002\/14651858. CD007503.pub2, Issue 3","DOI":"10.1002\/14651858.CD007503.pub2"},{"key":"846_CR63","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/rheumatology\/ken110","volume":"47","author":"S Perrot","year":"2008","unstructured":"Perrot S, Javier R-M, Marty M, Le Jeunne C, Laroche F: Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Rheumatology (Oxford). 2008, 47: 1117-1123. 10.1093\/rheumatology\/ken110.","journal-title":"Rheumatology (Oxford)"},{"key":"846_CR64","doi-asserted-by":"crossref","unstructured":"Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JWM: Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2011, Art. No. CD003460-10.1002\/14651858. CD003460.pub, Issue 8","DOI":"10.1002\/14651858.CD003460.pub3"},{"key":"846_CR65","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/gut.2008.163162","volume":"58","author":"AC Ford","year":"2009","unstructured":"Ford AC, Talley NJ, Schoenfeld PS, Quigley EMM, Moayyedi P: Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009, 58: 367-378. 10.1136\/gut.2008.163162.","journal-title":"Gut"},{"key":"846_CR66","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1365-2850.2009.01464.x","volume":"16","author":"PG McKay","year":"2009","unstructured":"McKay PG, Duffy T, Martin CR: Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention. J Psychiatr Ment Health Nurs. 2009, 16: 884-894. 10.1111\/j.1365-2850.2009.01464.x.","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"846_CR67","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0277-9536(02)00132-6","volume":"56","author":"B Sleath","year":"2003","unstructured":"Sleath B, Shih Y-CT: Sociological influences on antidepressant prescribing. Soc Sci Med. 2003, 56: 1335-1344. 10.1016\/S0277-9536(02)00132-6.","journal-title":"Soc Sci Med"},{"key":"846_CR68","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1001\/archinte.160.18.2825","volume":"160","author":"JR Mort","year":"2000","unstructured":"Mort JR, Aparasu RR: Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med. 2000, 160: 2825-2831. 10.1001\/archinte.160.18.2825.","journal-title":"Arch Intern Med"},{"issue":"Suppl 2","key":"846_CR69","doi-asserted-by":"publisher","first-page":"D59","DOI":"10.1016\/j.encep.2008.10.012","volume":"36","author":"X Briffault","year":"2010","unstructured":"Briffault X, Morvan Y, Rouillon F, Dardennes R, Lamboy B: [Factors associated with treatment adequacy of major depressive episodes in France]. Enc\u00e9phale. 2010, 36 (Suppl 2): D59-72.","journal-title":"Enc\u00e9phale"},{"issue":"Suppl 2","key":"846_CR70","doi-asserted-by":"publisher","first-page":"D48","DOI":"10.1016\/j.encep.2008.10.011","volume":"36","author":"X Briffault","year":"2010","unstructured":"Briffault X, Morvan Y, Rouillon F, Dardennes R, Lamboy B: [Use of services and treatment adequacy of major depressive episodes in France]. Enc\u00e9phale. 2010, 36 (Suppl 2): D48-58.","journal-title":"Enc\u00e9phale"},{"key":"846_CR71","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/SPC.0b013e328345a3ec","volume":"5","author":"BH Smith","year":"2011","unstructured":"Smith BH, Torrance N: Management of chronic pain in primary care. Curr Opin Support Palliat Care. 2011, 5: 137-142. 10.1097\/SPC.0b013e328345a3ec.","journal-title":"Curr Opin Support Palliat Care"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2296-14-55\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-14-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-14-55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-14-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T05:46:12Z","timestamp":1595742372000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/1471-2296-14-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,4]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1186\/1471-2296-14-55","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,4]]},"article-number":"55"}}